SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Endocare (ENDO)
ENDO 0.00010000.0%Oct 30 3:39 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Joseph Waligore who wrote (46)1/1/1999 2:46:00 PM
From: Juster  Read Replies (1) of 99
 
Joseph,

Twelve State approval now is not nearly the same as 50 States.
The latter means a real acceptance of their technology. Doctors
will be willing to get training on a generally accepted reimbursed
procedure. Then private insurance companys will start to cover it,
and perhaps hospitals and Doctors of other Countrys will take notice.
But if it becomes the treatment of choice how much competition will
bear down from companys with much bigger resources?

Juster
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News